70 related articles for article (PubMed ID: 3941713)
21. Low-dose cytarabine: chromosomal findings suggesting its cytostatic as well as differentiating effect.
Hossfeld DK; Weh HJ; Kleeberg UR
Leuk Res; 1985; 9(2):329-30. PubMed ID: 3990338
[TBL] [Abstract][Full Text] [Related]
22. High remission induction (traditional sino-western HOAP) regimen for acute nonlymphocytic leukemia.
Chin Med J (Engl); 1980 Aug; 93(8):565-8. PubMed ID: 6772409
[No Abstract] [Full Text] [Related]
23. High-dose cytosine arabinoside as consolidation chemotherapy for acute nonlymphocytic leukemia in remission.
Urabe A; Mizoguchi H; Hoshino S; Nomura T; Dan K; Toyama K; Kimura M; Ogawa T; Yamaguchi H; Mutoh Y
Int J Hematol; 1991 Feb; 54(1):75-7. PubMed ID: 1954354
[TBL] [Abstract][Full Text] [Related]
24. High-dose cytarabine for the treatment of blastic phase chronic myelogenous leukemia.
Herzig RH; Phillips GL; Lazarus HM; Wolff SN; Herzig GP
Cancer Treat Rep; 1985; 69(7-8):881-3. PubMed ID: 3860297
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia.
Fearon ER; Burke PJ; Schiffer CA; Zehnbauer BA; Vogelstein B
N Engl J Med; 1986 Jul; 315(1):15-24. PubMed ID: 3086723
[TBL] [Abstract][Full Text] [Related]
26. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
[TBL] [Abstract][Full Text] [Related]
27. Treatment of refractory leukemia with high-dose cytosine arabinoside.
Klener P; Háber J
Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
[TBL] [Abstract][Full Text] [Related]
28. A clonal complete remission in a patient with acute nonlymphocytic leukemia originating in a multipotent stem cell.
Jacobson RJ; Temple MJ; Singer JW; Raskind W; Powell J; Fialkow PJ
N Engl J Med; 1984 Jun; 310(23):1513-7. PubMed ID: 6717542
[No Abstract] [Full Text] [Related]
29. [Hypoplastic leukemia achieved long-term remission with low-dose cytosine arabinoside].
Fujisawa S; Kanamori H; Noguchi T; Maruta A; Ogawa K; Sakai R; Taguchi J; Tomita N; Kodama F; Okubo T
Rinsho Ketsueki; 1995 Jan; 36(1):56-8. PubMed ID: 7715078
[TBL] [Abstract][Full Text] [Related]
30. High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics.
Pommier Y; Pochat L; Marie JP; Zittoun RA
Cancer Treat Rep; 1983 Apr; 67(4):371-3. PubMed ID: 6850654
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
Cassileth PA; Katz ME
Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
[TBL] [Abstract][Full Text] [Related]
32. [Modified VAPA therapy in children with acute nonlymphocytic leukemia].
Morohashi F; Aonuma K; Katoh M; Kobayashi T; Hanaoka Y; Tsuji K; Norose N; Kawai H; Nakahata T; Tsukada M
Rinsho Ketsueki; 1986 Nov; 27(11):2101-6. PubMed ID: 3820627
[No Abstract] [Full Text] [Related]
33. Therapy of secondary acute nonlymphocytic leukemia.
Beltran G; Stuckey WJ
N Engl J Med; 1983 May; 308(21):1295-6. PubMed ID: 6573569
[No Abstract] [Full Text] [Related]
34. Low-dose ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a review of 20 years' experience.
Cheson BD; Simon R
Semin Oncol; 1987 Jun; 14(2 Suppl 1):126-33. PubMed ID: 3589688
[No Abstract] [Full Text] [Related]
35. Low-dose cytosine arabinoside in the treatment of acute nonlymphocytic leukemia.
Cavanna L; Di Stasi M; Fornari F; Civardi G; Sholli G; Montanari G; Buscarini L
Acta Haematol; 1988; 79(3):179-80. PubMed ID: 3128043
[No Abstract] [Full Text] [Related]
36. Extra Y chromosome in T-cell acute lymphoblastic leukemia.
Watanabe A; Kawachi Y; Nishihara T; Uchida T; Setsu K; Hikiji K
Cancer Genet Cytogenet; 1996 Jul; 89(1):85-7. PubMed ID: 8689620
[TBL] [Abstract][Full Text] [Related]
37. Cytarabine: low-dose, high-dose, no dose?
Desforges JF
N Engl J Med; 1983 Dec; 309(26):1637-9. PubMed ID: 6646187
[No Abstract] [Full Text] [Related]
38. Prognostic implications of in vitro colony studies and clonal chromosomal aberrations in adults with acute leukaemia.
Hörnsten P; Lindquist R; Gahrton G
Scand J Haematol; 1984 Mar; 32(3):297-305. PubMed ID: 6701466
[TBL] [Abstract][Full Text] [Related]
39. High dose araC in acute nonlymphocytic leukemia complicating Hodgkin's disease.
Manoharan A; Wegman E
Aust N Z J Med; 1983 Dec; 13(6):641. PubMed ID: 6586156
[No Abstract] [Full Text] [Related]
40. Chromosomal defects in acute nonlymphocytic leukemia.
N Engl J Med; 1981 Nov; 305(22):1348-9. PubMed ID: 7290160
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
